Skip to main content
Log in

Duchenne muscular dystrophy: Pathogenetic aspects and genetic prevention

  • Review Articles
  • Published:
Human Genetics Aims and scope Submit manuscript

Summary

Duchenne muscular dystrophy (DMD) is the most common sex linked lethal disease in man (one case in about 4000 male live births). The patients are wheelchair bound around the age of 8–10 years and usually die before the age of 20 years. The mutation rate, estimated by different methods and from different population studies, is in the order of 7×10-5, which is higher than for any other X-linked genetic disease. Moreover, unlike other X linked diseases such as hemophilia A or Lesh-Nyhan's disease, there seems to be no sex difference for the mutation rates in DMD. Several observations of DMD in girls bearing X-autosomal translocations and linkage studies on two X chromosomal DNA restriction fragment length polymorphisms indicate that the DMD locus is situated on the short arm of the X chromosome, between Xp11 and Xp22. It may be of considerable length, and perthaps consisting of actively coding and non-active intervening DNA sequences. Thus unequal crossing over during meiosis in females could theoretically account for a considerable proportion of new mutations.

However, there is no structurally or functionally abnormal protein known that might represent the primary gene product, nor has any pathogenetic mechanism leading to the observed biochemical and histological alterations been elucidated. Among the numerous pathogenetic concepts the hypothesis of a structural or/and functional defect of the muscular plasma membrane is still the most attractive. It would explain both the excess of muscular constituents found in serum of patients and carriers, such as creatine kinase (CK), as well as the excessive calcium uptake by dystrophic muscle fibres, which, prior to necrosis, could lead to hypercontraction, rupture of myofilaments in adjacent sarcomeres and by excessive Ca uptake to mitochondrial damage causing crucial energy loss.

The results of studies on structural and functional memthrane abnormalities in cells other than muscle tissue, e.g., erythrocytes, lymphocytes and cultured fibroblasts, indicate that the DMD mutation is probably demonstrable in these tissues. However, most of the findings are still difficult to reproduce or even controversial.

DMD is an incurable disease; therefore most effort, in research as well as in practical medicine, is concentrated upon its prevention. Unfortunately the disease cannot yet be diagnosed prenatally. Potential DMD carriers among female relatives of the patients may be identified by pathological heterozygote tests, of which determination of serum CK activity is probably still the most reliable method, allowing the detection of about 70% of adult and probably up to 90% of carriers at school age. Because of the high mutation rate, assessment of individual heterozygote risks in female relatives of isolated DMD cases is of special importance. For the calculations a maximum of genealogical and phenotype information on unaffected male and on heterozygote tests in female relatives is needed to obtain credible risk figures. However, estimating a consultand's risk and passing on this information is only one aspect of genetic counselling in DMD. At least as important is information on the medical, psychological and social impacts of the disease (burden) and the possibility of maintaining a long-term contact between the couples at risk and the team involved in medical, genetic and social problems of the disease. Neonatal CK screening for DMD, although without any therapeutical consequence, could theoretically lead to the prevention of “secondary” cases, accounting for some 15% of all DMD patients born, but an almost equal prevention rate of such cases would be achieved if CK examinations were limited to all boys with delayed motor development during the first 2 years of life. Finally, it is believed that the two most important preventive problems in DMD, carrier detection and prenatal diagnosis, will ultimately be solved by means of the rapidly advancing DNA technology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Accardo PJ (1981) An early case report of muscular dystrophy. A footnote to the history of neuromuscular disorders. Arch Neurol 38:144–146

    Google Scholar 

  • Adornato BT, Corash L, Engel WK (1977) Erythrocyte survival in Duchenne muscular dystrophy. Neurology 27:1093–1094

    Google Scholar 

  • Aebi U, Richterich R, Stillhart H, Colombo JP, Rossi E (1961) Progressive Muskeldystrophie. III. Serumenzyme bei der Muskeldystrophie im Kindesalter. Helv Paediatr Acta 16:543–564

    Google Scholar 

  • Afifi AK, Bergman RA, Zellweger H (1973) A possible role for electron microscopy in detection of carriers of Duchenne type muscular dystrophy. J Neurol Neurosurg Psychiatry 36:643–650

    Google Scholar 

  • Ahmad M, Sanderson JE, Dubowitz V, Hallidie-Smith KA (1978) Echocardiographic assessment of left ventricular function in Duchenne's muscular dystrophy. Br Heart J 40:734–740

    Google Scholar 

  • Alberts MC, Samaha FJ (1974) Serum pyruvate kinase in muscle disease and carrier states. Neurology 24:462–464

    Google Scholar 

  • Allen JE, Rodgin DW (1960) Mental retardation in association with progressive muscular dystrophy. Am J Dis Child 100:208–211

    Google Scholar 

  • Ando T, Shimizu T, Kato T, Ohsawa M, Fukuyama Y (1978) Myoglobinemia in children with progressive muscular dystrophy. Clin Chim Acta 85:17–22

    Google Scholar 

  • Araki S, Mawatari S (1971) Ouabain and erythrocyte ghost adenosine triphosphatase. Effects in human muscular dystrophies. Arch Neurol 24:187–190

    Google Scholar 

  • Austin L, Katz S, Jeffrey PL, Shield L, Arthur H, Mazzoni M (1983) Thermodynamic behaviour of membrane enzymes in Duchenne muscular dystrophy. J Neurol Sci 58:143–151

    Google Scholar 

  • Ballantyne JP, Hansen S (1974) New method for the estimation of the number of motor units in a muscle: II. Duchenne, limbgirdle and facioscapulohumeral and myotonic muscular dystrophies. J Neurol Neurosurg Psychiatry 37:1195–1201

    Google Scholar 

  • Becker PE (1953) Dystrophia musculorum progressiva. Thieme, Stuttgart

    Google Scholar 

  • Becker PE (1964) Myopathien. In: Becker PE (ed) Humangenetik. Ein kurzes Handbuch in 5 Bänden, Bd III/1. Thieme, Stuttgart, pp 420–427

    Google Scholar 

  • Becker PE (1972) Neues zur Genetik und Klassifikation der Muskeldystrophien. Humangenetik 17:1–22

    Google Scholar 

  • Becker PE, Kiener F (1955) Eine neue X-chromosomale Muskeldystrophie. Arch Psychiatr Z Neurol 193:427–448

    Google Scholar 

  • Becker PE, Lenz F (1955, 1956) Zur Schätzung der Mutationsrate der Muskeldystrophien. Z menschl Vererb Konstitutionsl 33: 42–56

    Google Scholar 

  • Beckmann R, Scheuerbrandt G (1979) Screening auf erhöhte Kreatinkinase-Aktivitäten zur Früherkennung der Duchenne-Muskeldystrophie. Fortschr Med 97:1733–1736

    Google Scholar 

  • Berg G, Conte F (1974) Duchenne dystrophy in a female with a structurally abnormal X-chromosome. Neurology 24:356

    Google Scholar 

  • Bertorini TE, Bhattacharya SK, Palmieri GMA, Chesney CM, Pifer D, Baker B (1982) Muscle calcium and magnesium content in Duchenne muscular dystrophy. Neurology 32:1088–1092

    Google Scholar 

  • Beyer P, Stephan M, Oberling F, Daya Y (1977) Deformation des erythrocytes chez les sujets atteints de myopathie de Duchenne de Bologne. Presse Méd 6:1663–1664

    Google Scholar 

  • Biggs R, Rizza CR (1976) The sporadic case of hemophilia A. Lancet ii:431–433

    Google Scholar 

  • Bitter K (1964) Erhebungen zur Bestimmung der Mutationsrate für Haemophilie A und B in Hamburg. Z Menschl Vererb Konstitutionsl 37:251–268

    Google Scholar 

  • Blith H, Pugh RJ (1959) Muscular dystrophy in childhood. The genetic aspect. Ann Hum Genet 23:127–163

    Google Scholar 

  • Bodensteiner JB, Engel AG (1978) Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: A study of 567 000 muscle fibres in 114 biopsies. Neurology 28:439–446

    Google Scholar 

  • Boulé M, Vanasse M, Brakier-Gingras L (1979) Decrease in the rate of protein synthesis from cultured fibroblasts of patients and carriers with Duchenne muscular dystrophy. J Canad Sci Neurol 6:355–358

    Google Scholar 

  • Boxler K, Jerusalem F (1978) Hyperreactive (hyaline, opaque, dark) muscle fibres in Duchenne dystrophy. A biopsy study of 16 dystrophy and 205 other neuromuscular disease cases and controls. J Neurol 219:63–72

    Google Scholar 

  • Bradley WG, Fullthorpe JJ (1978) Studies of sarcolemmal integrity in myopathic muscle. Neurology 28:670–676

    Google Scholar 

  • Bradley WG, Kelemen J (1979) Editorial: Genetic counseling in Duchenne muscular dystrophy. Muscle and Nerve 2:325–327

    Google Scholar 

  • Brambati B, Cornelio F, Dworzak F, Dones I (1980) Calciumpositive muscle fibres in fetuses at risk for Duchenne muscular dystrophy. Lancet ii:969–970

    Google Scholar 

  • Brooks AP, Emery AEH (1977) The incidence of Duchenne muscular dystrophy in the south east of Scotland. Clin Genet 11:290–294

    Google Scholar 

  • Brown HD, Chattpadhyay SK, Patel AB (1967) Erythrocyte abnormality in human myopathy. Science 157:1577–1578

    Google Scholar 

  • Brown WF (1974) Sources of error in the methods for estimating motor unit numbers in the EDB and thenar muscles. III International Congress on Muscle Disease. Internat Congr Ser 334, Excerpta Medica, Abstr 190, pp 108–115

  • Bucher K, Ionasescu V, Hanson J (1980) Frequency of new mutants among boys with Duchenne muscular dystrophy. Am J Med Genet 7:27–46

    Google Scholar 

  • Bundey S (1981) A genetic study of Duchenne muscular dystrophy in the West Midlands. J Med Genet 18:1–7

    Google Scholar 

  • Bundey S, Crawley JM, Edwards JH, Westhead RA (1979a) Serum creatine kinase levels in pubertal, mature, pregnant, and postmenopausal women. J Med Genet 16:117–121

    Google Scholar 

  • Bundey S, Edwards JH, Insley J (1979b) Carrier detection in Duchenne muscular dystrophy. Lancet i:881

    Google Scholar 

  • Burghes AHM, Dunn MJ, Statham HE, Dubowitz V (1981) Analysis of cultured skin fibroblasts from patients with Duchenne muscular dystrophy using electrophoretic techniques. In: Allen RC, Arnaud P (eds) Electrophoresis '81. Walter de Gruyter, Berlin, pp 285–308

    Google Scholar 

  • Burghes AHM, Dunn MJ, Statham HE, Dubowitz V (1982a) Analysis of fibroblast proteins in Duchenne muscular dystrophy: 1. Sodium dodecyl sulphate polyacrylamide gel electrophoresis. Electrophoresis 3:177–185

    Google Scholar 

  • Burghes AHM, Dunn MJ, Statham HE, Dubowitz V (1982b) Analysis of skin fibroblast proteins in Duchenne muscular dystrophy: 2. Isoelectric focusing under dissociating conditions. Electrophoresis 3:185–196

    Google Scholar 

  • Butterfield DA, Markesbery WR (1980) Specifity of biophysical and biochemical alterations in erythrocyte membranes in neurological disorders. Huntington's disease, Friedreich's ataxia, Alzheimer's disease, amyotrophic lateral sclerosis, and myotonic and Duchenne muscular dystrophy. J Neurol Sci 47:261–271

    Google Scholar 

  • Butterfield DA, Chesnut DB, Appel SH, Roses AD (1976) Spin label study of erythrocyte membrane fluidity in myotonic and Duchenne dystrophies and myotonia congenita. Nature 263:159–161

    Google Scholar 

  • Canal N, Frattola L, Smirne S (1975) The metabolism of cyclic 3′-5′-adenosine monophosphatase (cAMP) in diseased muscle. J Neurol 208:259–265

    Google Scholar 

  • Canki N, Dutrillaux B, Tivadar I (1979) Dystrophie musculaire de Duchenne chez une petite fille proteuse d'une translocation t(X;3) (p21;q13) de novo. Ann Génet 22:35–39

    Google Scholar 

  • Carpenter S, Karpati G (1979) Duchenne muscular dystrophy. Plasma membrane loss initiates muscle cell necrosis unless it is repaired. Brain 102:147–161

    Google Scholar 

  • Carter ND, Heath R, Jeffrey S, Rodeck C (1982) Fetal plasma carbonic anhydrase III in Duchenne dystrophy. Lancet i:39–40

    Google Scholar 

  • Caskey CT, Nussbaum RL, Cohan LC, Pollack L (1980) Sporadic occurrence of Duchenne muscular dystrophy: evidence for new mutation. Clin Genet 18:329–341

    Google Scholar 

  • Cerri CG, Willner JH, Mirande AF (1982) Adenylate cyclase in Duchenne fibroblasts. J Neurol Sci 53:181–185

    Google Scholar 

  • Cheeseman EA, Kilpatrick SJ, Stevenson AC, Smith CAB (1958) The sex ratio of mutation rates of sex-linked recessive genes in man with particular reference to Duchenne type muscular dystrophy. Ann Hum Genet 22:235–243

    Google Scholar 

  • Chung CS, Morton NE (1959) Discrimination of genetic entities in muscular dystrophy. Am J Hum Genet 11:339–359

    Google Scholar 

  • Cöers C, Telerman-Topet N, Gerard JH (1973) Terminal innervation ratio in neuromuscular disease: II. Disorders of lower motor neuron, peripheral nerve, and muscle. Arch Neurol 29:215–222

    Google Scholar 

  • Coneally PM, Heuch I (1974) A computer program to determine genetic risks: a simplified version of PEDIG (Heuch and Li, 1972). Am J Hum Genet 26:773–775

    Google Scholar 

  • Conlon T, Lingard PS, Tomkins JK (1983) Deformability and cell membrane properties of erthrocytes in Duchenne muscular dystrophy. Clin Chim Acta 130:139–147

    Google Scholar 

  • Cowan J, MacDessi J, Stark A, Morgan G (1980) Incidence of Duchenne muscular dystrophy in New South Wales and the Australian capital territory. J Med Genet 17:245–249

    Google Scholar 

  • Crisp DE, Ziter FA, Bray PF (1982) Diagnostic delay in Duchenne's muscular dystrophy. JAMA 247:478–480

    Google Scholar 

  • Cullen MJ, Fulthorpe JJ (1975) Stages in fibre breakdown in Duchenne muscular dystrophy. J Neurol Sci 24:179–200

    Google Scholar 

  • Cullen MJ, Parsons R (1977) Inclusion bodies in muscular dystrophy. Lancet ii:929

    Google Scholar 

  • Cullen MJ, Mastaglia FL (1980) Morphological changes in dystrophic muscle. Br Med Bull 36:145–152

    Google Scholar 

  • Danieli GA, Mostacciulo ML, Bonfante A, Angelini C (1977) Duchenne muscular dystrophy. A population study. Hum Genet 35:225–231

    Google Scholar 

  • Danieli GA, Mostacciulo ML, Pilotto G (1978) Duchenne mutation rate. IRCS Medical Science 6:440

    Google Scholar 

  • Danieli GA, Mostacciulo ML, Pilotto G, Angelini C, Bonfonge A (1980) Duchenne muscular dystrophy. Data from family studies. Hum Genet 54:63–68

    Google Scholar 

  • Danilowicz D, Rutkowski M, Myung D, Schively D (1980) Echocardiography in Duchenne muscular dystrophy. Muscle and Nerve 3:298–303

    Google Scholar 

  • Davie AM, Emery AEH (1978) Estimation of proportion of new mutants among cases of Duchenne muscular dystrophy. J Med Genet 15:339–345

    Google Scholar 

  • Davies KE, Young BD, Elles RG, Hill ME, Williamson R (1981) Cloning of a representative genomic library of the human X chromosome after sorting by flow cytometry. Nature 293: 374–376

    Google Scholar 

  • Davies KE, Pearson PL, Harper PS, Murray JM, O'Brien T, Sarfarazi M, Williamson R (1983) Linkage analysis of two cloned DNA sequences flanking the Duchenne muscular dystrophy locus on the short arm of the human X chromosome. Nucleic Acids Res 11:2303–2312

    Google Scholar 

  • Dellamonica C, Collombel C, Cotte J, Addis P (1983) Screening for neonatal Duchenne muscular dystrophy by bioluminiscence measurement of creatine kinase in a blood sample spotted on paper. Clin Chem 29:161–163

    Google Scholar 

  • Dennis NR, Evans K, Clayton B, Carter CO (1976) Use of creatine kinase for detecting severe X-linked muscular dystrophy carriers. Br Med J 2:577–579

    Google Scholar 

  • Dhalla NS, McNamara DB, Balasubramian V, Greenlaw R, Tucker FR (1973) Alterations of adenosine triphosphatase activities in dystrophic muscle sarcolemma. Res Commun Chem Pathol Pharmacol 6:643–650

    Google Scholar 

  • Drachman DB, Toyka KV, Myer E (1974) Prednisone in Duchenne muscular dystrophy. Lancet ii:1409–1412

    Google Scholar 

  • Dreyfus JC, Schapira G (1962) Biochemistry of hereditary myopathies. Springfield, Charles C Thomas

    Google Scholar 

  • Dreyfus JC, Schapira G, Schapira F (1954) Biochemical study of muscle in progressive muscular dystrophy. J Clin Invest 33: 794–797

    Google Scholar 

  • Drummond LM (1979) Creatine phosphokinase levels in the newborn and their use in screening for Duchenne muscular dystrophy. Arch Dis Child 54:362–366

    Google Scholar 

  • Dubowitz V (1960) Progressive muscular dystrophy of the Duchenne type in females and its mode of inheritance. Brain 83:432–439

    Google Scholar 

  • Dubowitz V (1963) Myopathic changes in muscular dystrophy carriers. Proc R Soc Med 56:810–812

    Google Scholar 

  • Dubowitz V (1965) Intellectual impairment in muscular dystrophy. Arch Dis Child 40:296–301

    Google Scholar 

  • Dubowitz V (1978) Muscle disorders in childhood. In: Schaffer AJ, Markowitz M (eds) Major problems in clinical pediatrics, vol XVI. Saunders, London Philadelphia Toronto

    Google Scholar 

  • Dubowitz V (1982) The female carrier of Duchenne muscular dystrophy. Br Med J 284:1423–1424

    Google Scholar 

  • Dubowitz V, Crome L (1969) The central nervous system in Duchenne muscular dystrophy. Brain 92:805–808

    Google Scholar 

  • Dubowitz V, Van Iddeninge D, Rodeck CH, Campbell S, Singer JD, Scheuerbrandt G, Moss DW (1978) Prenatal diagnosis in Duchenne muscular dystrophy: salvage of a normal male fetus. Lancet i:90

    Google Scholar 

  • Duchenne de Boulogne GBA (1861) De l'éctrisation localisée et de son application à la pathologie et la thérapeutique. J. B. Baillière & Pils, Paris

    Google Scholar 

  • Duchenne de Boulogne GBA (1868) Recherches sur la paralysie musculaire pseudohypertrophique, ou paralysie myosclérosique. Arch Gén Méd 11:5–25; 179–209; 305–321; 421–443; 552–588

    Google Scholar 

  • Duncan CJ (1978) Role of intracellular calcium in promoting muscle damage: a strategy for controlling the dystrophic condition. Experienta 34:1531–1535

    Google Scholar 

  • Ebashi S, Sugita H (1979) The role of calcium in physiological and pathological processes of skeletal muscle. In: Aguayo AJ, Karpati G (eds) Current topics in nerve and muscle research Amsterdam: Excerpta Medica, ICS No 445, pp 73–84

    Google Scholar 

  • Ebashi S, Toyokura Y, Momoi H, Sugita H (1959) High creatine phosphokinase activity of sera of progressive muscular dystrophy patients. J Biochem (Tokyo) 46:103–104

    Google Scholar 

  • Emery AEH (1964) Lyonisation of the X-chromosome. Lancet i:884

    Google Scholar 

  • Emery AEH (1965) Muscle histology in carriers of Duchenne muscular dystrophy. I Med Genet 2:1–7

    Google Scholar 

  • Emery AEH (1966a) Genetic linkage between the loci for colour blindness and Duchenne type muscular dystrophy. J Med Genet 3:92–95

    Google Scholar 

  • Emery AEH (1966b) The use of serum creatine kinase for detecting carriers of Duchenne muscular dystrophy. In: Exploratory concepts in muscular dystrophy and related disorders. International Congress Series No 147 Excerpta Medica, Amsterdam, pp 90–97

    Google Scholar 

  • Emery AEH (1969a) Abnormalities of the electrocardiogram in female carriers of Duchenne muscular dystrophy. Br Med J 2: 418–420

    Google Scholar 

  • Emery AEH (1969b) Genetic counselling in X-linked muscular dystrophy. J Neurol Sci 8:579–587

    Google Scholar 

  • Emery AEH (1977a) Muscle histology and creatine kinase levels in the foetus in Duchenne muscular dystrophy. Nature 266: 472–473

    Google Scholar 

  • Emery AEH (1977b) Genetic considerations in the X-linked muscular dystrophies. In: Rowland LP (ed) Pathogenesis of human muscular dystrophies. Excerpta Medica Amstedam, pp 42–58

    Google Scholar 

  • Emery AEH (1980) Duchenne muscular dystrophy. Genetic aspects, carrier detection and antenatal diagnosis. Br Med Bull 36:117–122

    Google Scholar 

  • Emery AEH (1981) Genetic aspects of neuromuscular disease. In: Walton J (ed) Disorders of voluntary muscle, 4th ed. Churchill Livingstone, Edinburgh London Melbourne New York, pp 785–807

    Google Scholar 

  • Emery AEH, Skinner R (1976) Clinical studies in benign (Becker type) X-linked muscular dystrophy. Clin Genet 10:189–201

    Google Scholar 

  • Emery AEH, Holloway S (1977) Use of normal daughters' and sisters' creatine kinase levels in estimating heterozygosity in Duchenne muscular dystrophy. Hum Hered 27:118–126

    Google Scholar 

  • Emery AEH, Burt D (1980) Intracellular calcium and pathogenesis and antenatal diagnosis of Duchenne muscular dystrophy. Br Med J 1:355–357

    Google Scholar 

  • Emery AEH, Smith CAB, Sanger R (1968/1969) The linkage relations of the loci for benign (Becker type) X-borne muscular dystrophy, colour blindness and the Xg blood groups. Ann Hum Genet 32:261–269

    Google Scholar 

  • Emery AEH, Watt MS, Clack ER (1972) The effects of genetic counselling in Duchenne muscular dystrophy. Clin Genet 3: 147–150

    Google Scholar 

  • Emery AEH, Burt D, Dubowitz V, Rocker I, Donnai D, Harris R, Donnai P (1979a) Antenatal diagnosis of Duchenne muscular dystrophy. Lancet i:847–849

    Google Scholar 

  • Emery AEH, Skinner R, Holloway S (1979b) A study of possible heterogeneity in Duchenne muscular dystrophy. Clin Genet 15:444–449

    Google Scholar 

  • Engel WK (1967) Muscle biopsies in neuromuscular diseases. Pediatr Clin N Am 14:963–965

    Google Scholar 

  • Engel WK (1971) Nouvelle hypothèse sur la pathogénie de la dystrophie musculaire pseudo-hypertrophique de Duchenne. Rev Neurol 124:291–298

    Google Scholar 

  • Erb WH (1891) Dystrophia muscularis progressiva: Klinische und pathologisch anatomische Studien. Dtsch Z Nervenheilk 1:13–94

    Google Scholar 

  • Eulenburg von A (1866) Ergebnisse der anatomischen Untersuchung eines Falles von sogenannter Muskelhypertrophie. Verhandl Berliner Med Gest 1:191

    Google Scholar 

  • Falk RS, Campion D, Guthrie D, Sparkes RS, Fox CF (1979) Phosphorylation of red-cell membrane proteins in Duchenne muscular dystrophy. N Engl J Med 300:258–259

    Google Scholar 

  • Fenichel GM (1975) On the pathogenesis of Duchenne muscular dystrophy. Dev Med Child Neurol 17:527–533

    Google Scholar 

  • Ferrier P, Bamatter F, Klein D (1965) Muscular dystrophy (Duchenne) in a girl with Turner's syndrome. J Med Genet 2:38–46

    Google Scholar 

  • Firth MA, Wilkinson EJ (1983) Screening the newborn for Duchenne muscular dystrophy: parents' view. Br Med J 286:1933–1934

    Google Scholar 

  • Fischer S, Tortolero M, lau JP, Delauney J, Schapira G (1978) Protein kinase and adenylate cyclase or erythrocyte membrane proteins from patients with Duchenne muscular dystrophy. Clin Chim Acta 88:437–440

    Google Scholar 

  • Fisher ER, Wissinger HA, Gerneth JA, Danowski TS (1972) Ultrastructural changes in skeletal muscle of muscular dystrophy carriers. Arch Pathol 94:456–460

    Google Scholar 

  • Fisher ER, Silverstri E, Vester JW, Nolan S, Ahmed U, Danowski T (1976) Increased erythrocyte osmotic fragility in pseudohypertrophic muscular dystrophy. JAMA 236:955

    Google Scholar 

  • Francke U, Felsenstein J, Gartler SM, Migeon BR, Dancis J, Seegmiller JE, Bakay F, Nyhan WL (1976) The occurrence of new mutants in the X-linked recessive Lesch-Nyhan disease. Am J Hum Genet 28:123–137

    Google Scholar 

  • Francke U, Felsenstein J, Gartler SM, Nyhan WL, Seegmiller JE (1977) Answer to criticism of Morton and Laloue (Letter to the editor). Am J Hum Genet 29:307–310

    Google Scholar 

  • Fritsch EF, Lawn RM, Maniatis T (1980) Molecular cloning and characterization of the human β-like globin gene cluster. Cell 19:959–972

    Google Scholar 

  • Fuhrmann W, Vogel F (1982) Genetische Familienberatung. Ein Leitfaden für Studierende und Aerzte, 3. Aufl. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Gaines RF, Pueschel SM, Sassaman EA, Driscoll JL (1982) Effect of exercise on serum creatine kinase in carriers of Duchenne muscular dystrophy. J Med Genet 19:4–7

    Google Scholar 

  • Gale AN, Murphy EA (1979) The use of serum creatine phosphokinase in genetic couseling for Duchenne muscular dystrophy. II: Review of methods of assay and factors which may be relevant in the interpretation of serum creatine phosphokinase activity. J Chron Dis 32:639–651

    Google Scholar 

  • Gardner-Medwin D (1968) Studies of the carrier state in Duchenne type muscular dystrophy. Quantitative electromygraphy as a method of carrier detection. J Neurol Neurosurg Psychiatr 31: 121–134

    Google Scholar 

  • Gardner-Medwin D (1970) Mutation rate in Duchenne type of muscular dystrophy. J Med Genet 7:334–337

    Google Scholar 

  • Gardner-Medwin D (1979) Controversies about Duchenne muscular dystrophy. (1) Neonatal screening. Dev Med Child Neurol 21: 390–393

    Google Scholar 

  • Gardner-Medwin D (1980) Clinical features and classification of the muscular dystrophies. Br Med Bull 36:109–115

    Google Scholar 

  • Gardner-Medwin D, Pennington RJ, Walton JN (1971) The detection of carriers of X-linked muscular dystrophy genes. A review of some methods studied in Newcastle upon Tyne. J Neurol Sci 13:459–474

    Google Scholar 

  • Gardner-Medwin D, Bundey S, Green S (1978) Early diagnosis of Duchenne muscular dystrophy. Lancet i:1102

    Google Scholar 

  • Garceau C, Leblond PF, Lyonnais J, Beaupré A (1978) Morphologie et déformabilité des érythrocytes dans la dystrophie musculaire. Nouv Rev Fr Hématol Blood Cells 20:585–598

    Google Scholar 

  • Gershwin ME, Taylor RG, Fowler WM, Finlayson B (1979) Failure to demonstrate abnormal lymphocyte capping in humans, mice and hamsters with muscular dystrophy. Hum Genet 53:113–114

    Google Scholar 

  • Godin DV, Bridges MA, MacLeod PJM (1978) Chemical composition studies of erythrocyte membranes in Duchenne muscular dystrophy. Res Commun Chem Pathol Pharmacol 20:331–350

    Google Scholar 

  • Golbus MS, Stephens JD, Mahoney MJ, Hobbins JC, Haseltine FP, Caskey CT, Banker BQ (1979) Failure of fetal creatine phosphokinase as a diagnostic indicator of Duchenne muscular dystrophy. N Engl J Med 300:860–861

    Google Scholar 

  • Goldsmith BM, Gruemer HD, Hawley RJ, Pickard NA, Verril HL, Nance WE, Miller G, Crawford RG (1980) The contribution of assays for lymphocyte capping and creatine kinase to detection of the Becker-type dystrophy trait. Clin Chem 26:754–759

    Google Scholar 

  • Gossens M, Dozy AM, Embyry SH, Zachariades Z, Hadjiminas MG, Stamatoyannopoulos G, Kan YW (1980) Triplicated α-globin loci in humans. Proc Natl Acad Sci 77:518–521

    Google Scholar 

  • Gowers WR (1879) Pseudo-hypertrophic muscular paralysis. J A Churchill, London

    Google Scholar 

  • Grassi E, Lucci B, Marchini C, Ottonello S, Parma M, Reggiani R, Rossi GL, Tagliavini J (1977) II problema delle alterazioni eritrocitarie (echnio e stomatocitche) nella distrofia muscolare. Ateno Parmense (Acta Biomed) 48:297–327

    Google Scholar 

  • Grassi E, Lucci B, Marchini C, Ottonello S, Parma M, Reggiani R, Rossi GL, Tagliavini J (1978) Deformed erythrocytes in muscular dystrophies. Neurology 28:842–844

    Google Scholar 

  • Greenstein RM, Reardon MP, Chan TS, Middleton AB, Mulivor RA, Green AE, Coriell LL (1980) An (X;11) translocation in a gril with Duchenne muscular dystrophy. Repository identification no. GM 1695. Cytogenet Cell Genet 27:268

    Google Scholar 

  • Grimm T (1981) Neugeborenen-Screening nach Duchennescher Muskeldystrophie. Monatsschr Kinderheilk 129:414–417

    Google Scholar 

  • Haldane JBS (1935) The rate of spontaneous mutation of a human gene. J Genet 31:317–326

    Google Scholar 

  • Haldane JBS (1956) Mutation in the sex-linked recessive type of muscular dystrophy. A possible sex difference. Ann Hum Genet 20:344–347

    Google Scholar 

  • Hammond DT, Jackson CE (1958) Consanguinity in a midwestern United States isolate. Am J Hum Genet 10:61–63

    Google Scholar 

  • Hathaway PW, Engel WK, Zellweger H (1970) Experimental myopathy after microarterial embolization. Comparison with childhood X-linked pseudohypertrophic muscular dystrophy. Arch Neurol 22:365–377

    Google Scholar 

  • Hauser SL, Weiner H, Ault K, Unanue E (1979a) Lymphocyte capping in muscular dystrophy. N Engl J Med 300:861

    Google Scholar 

  • Hauser SL, Weiner HL, Bresnan MJ, Ault KA (1979b) Lymphocyte capping in muscular dystrophy. Neurology 29:1419–1421

    Google Scholar 

  • Hausmanowa-Petrusewicz I, Prot J, Niebrój-Dobosz I (1968) Studies of healthy relatives of patients with Duchenne muscular dystrophy. J Neurol Sci 7:465–480

    Google Scholar 

  • Hausmanowa-Petrusewicz I, Prot J, Dobosz I, Emeryk B, Roswinska K, Rubach K, Kopéc A, Kopéc J (1971) Further studies concerning the detection of carriership in the Duchhenne type of dystrophy. Eur Neurol 5:186–196

    Google Scholar 

  • Hausmanowa-Petrusewicz I, Niebroj-Dobosz I, Borkowsak J, Lukasik E, Liszewska-Pfejfer D (1977) Carrier detection in Duchenne dystrophy. In: Rowland LP (ed) Pathogenesis of human muscular dystrophies. Amsterdam, Excerpta Medica, pp 32–41

    Google Scholar 

  • Hausmanowa-Petrusewicz I, Wierzhicka M, Jozwik A, Szmidt-Salkowska E, Borkowska J (1982) A nearest neighbur decision rule for EMG detection of carriers of Duchenne muscular dystrophy. Electromyogr Clin Neurophysiol 22:445–457

    Google Scholar 

  • Heller A (1866) Klinische Beobachtungen über die bisher als Muskelhypertrophie bezeichnete Lipomatosis luxurians musculorum progressiva. Dtsch Arch Klin Med 1:616

    Google Scholar 

  • Herrmann FH, Spiegler A, Wiedemann G (1982) Muscle provocation test. A sensitive method for discrimination between carriers and noncarriers of Duchenne muscular dystrophy. Hum Genet 61:102–104

    Google Scholar 

  • Herrmann J (1966) Der Einfluss des Zeugungsalters auf die Mutation zu Hämophilie A. Humangenetik 3:1–16

    Google Scholar 

  • Heuch I, Li FHF (1972) PEDIG—a computer programme for calculation of genotype probabilities using phenotype information. Clin Genet 3:501–504

    Google Scholar 

  • Heyck H, Laudahn G (1969) Die progressiv-dystrophischen Myopathien. Springer, Berlin

    Google Scholar 

  • Hinderberger P, Moser H, Beck EA, Pflugshaupt R (1980) Heterozygotenerfassung bei der Hämophilie A—Genealogische und biochemische Resultate einer Feldstudie and 25 Bluterfamilien. Schweiz Rundschau Med (PRAXIS) 69:1349–1360

    Google Scholar 

  • Ho AD, Reitter B, Stojakowits S, Fiehn W, Weisser J (1980a) Capping of lymphocytes for carrier detection in Duchenne muscular dystrophy: Technical problems and a review of the literature. Eur J Pediatr 134:211–216

    Google Scholar 

  • Ho AD, Stojakowits S, Reitter B, Fiehn W, Zipperle G, Hunstein E, Lipinski CH (1980b) Capping of lymphocytes in patients and carriers of Duchenne muscular dystrophy. Klin Wschr 58:377–381

    Google Scholar 

  • Hodson A, Pleasure D (1977) Erythrocyte cation-activated adenosine triphosphatases in Duchenne muscular dystrophy. J Neurol Sci 32:361–369

    Google Scholar 

  • Horenstein AL, Emery AEH (1980) Human lymphocyte capping in Duchenne muscular dystrophy. Neurology 30:1330–1332

    Google Scholar 

  • Howells KF (1976) Structural changes of erythrocyte membranes in muscular dystrophy. Res Exp Med 168:213–217

    Google Scholar 

  • Howland JL, Iver SL (1977) Erythrocyte lipids in heterozygous carriers of Duchenne muscular dystrophy. Science 198:309–310

    Google Scholar 

  • Hudgson P, Gardner-Medwin D, Pennington RJT, Walton JN (1967) Studies of the carrier state in the Duchenne type of muscular dystrophy. I. Effect of exercise on serum creatine kinase activity. J Neurol Neurosurg Psychiatry 30:416–419

    Google Scholar 

  • Hughes RC, Park DC, Parsons ME, O'Brien MD (1971) Serum creatine kinase studies in the detection of carriers of Duchenne dystrophy. J Neurol Neurosurg Psychiatry 34:527–530

    Google Scholar 

  • Hulten M, Luciani JM, Kirton V, Devictor-Vullet M (1978) The use and limitations of chiasma scoring with reference to human genetic mapping. Cytogenet Cell Genet 22:37–58

    Google Scholar 

  • Hunsaker RH, Fulkerson PK, Barry FJ, Lewis RP, Leier CV, Unverferth DV (1982) Cardiac function in Duchenne's muscular dystrophy. Results of 10-year-follow-up study and noninvasive tests. Am J Med 73:235–238

    Google Scholar 

  • Hunter MIS, Lao MS, de Vane PJ (1982) Is erythrocyte membrane phospholipid organisation abnormal in Duchenne muscular dystrophy. Clin Chim Acta 128:69–74

    Google Scholar 

  • Hutton EM, Thompson MW (1976) Carrier detection and genetic counselling in Duchenne muscular dystrophy. A follow-up study. Can Med Ass J 115:749–752

    Google Scholar 

  • Ionasescu V, Zellweger H (1974) Duchenne muscular dystrophy in young girls? Acta Neurol Scand 50:619–630

    Google Scholar 

  • Ionasescu V, Zellweger H, Shirk P, Conway T (1973) Identification of carriers of Duchenne muscular dystrophy by muscle protein synthesis. Neurology 23:497–502

    Google Scholar 

  • Ionasescu V, Radu H, Nicolescu P (1975) Identification of Duchenne muscular dystrophy carriers. Arch Pathol 99:436–441

    Google Scholar 

  • Ionasescu V, Lara-Braud C, Zellweger H, Ionasescu R, Burmeister L (1977) Fibroblast cutures in Duchenne muscular dystrophy. Acta Neurol Scand 55:407–417

    Google Scholar 

  • Ionasescu V, Zellweger H, Cancilla P (1978) Fetal serum creatine phosphokinase not a valid predictor of Duchenne muscular dystrophy. Lancet ii:1251

    Google Scholar 

  • Ionasescu V, Burmeister L, Hanson J (1980) Discriminant analysis of ribosomal protein synthesis findings in carrier detection of Duchenne muscular dystrophy. Am J Med Genet 5:5–12

    Google Scholar 

  • Iyer SL, Hoenig PA, Sherblom AP, Howland JL (1977) Membrance function affected by genetic muscular dystrophy. I. Erythrocyte ghost protein kinase. Biochem Med 18:384–391

    Google Scholar 

  • Jackson CE, Carey JH (1961) Progressive muscular dystrophy: autosomal recessive type. Pediatrics 28:77–84

    Google Scholar 

  • Jacobs PA, Hunt PA, Mayer M, Bart RD (1981) Duchenne muscular dystrophy (DMD) in a female with an X/autosome translocation: Further evidence that the DMD locus in at Xp21. Am J Hum Genet 33:513–518

    Google Scholar 

  • Jalbert P, Mouriquand C, Beaudoing A, Jaillard M (1966) Myopathie progressive de type Duchenne et mosaique XO/XX/XXX: Considération sur la génèse de la fibre musculaire striée. Ann Génét 9:104–108

    Google Scholar 

  • Jellett LB, Kennedy MC, Goldblatt E (1974) Duchenne pseudohypertrophic muscular dystrophy. A clinical and electrocardiographic study of patients and female carriers. Aust NZ J Med 4:41–47

    Google Scholar 

  • Jerusalem F, Engel AG, Gomez MR (1974a) Duchenne dystrophy: Morphometric study of the muscle microvasculature. Brain 97: 115–122

    Google Scholar 

  • Jerusalem F, Engel AG, Gomez MR (1974b) Duchenne dystrophy: II. Morphometric study of motor end-plate fine structure. Brain 97:123–130

    Google Scholar 

  • Johnston HA (1964) Severe muscular dystrophy in girls. J Med Genet 1:79–81

    Google Scholar 

  • Jones GE, Witkowski JA (1979) Reduced adhesiveness between skin fibroblasts from patients with Duchenne muscular dystrophy. J Neurol Sci 43:465–470

    Google Scholar 

  • Jones GE, Witkowski JA (1981) Analysis of skin fibroblasts from patients with Duchenne muscular dystrophy. J Cell Sci 48: 291–300

    Google Scholar 

  • Jones GE, Witkowski JA (1983a) Membrane abnormalities in Duchenne muscular dystrophy. J Neurol Sci 58:159–174

    Google Scholar 

  • Jones GE, Severs NJ, Witkowski JA (1983) Freeze-fracture analysis of plasma membranes in Duchenne muscular dystrophy. A study using cultured skin fibroblasts. J Neurol Sci 58:185–193

    Google Scholar 

  • Jones GE, Witkowski JA (1983b) A cell surface abnormality in Duchenne muscular dystrophy: intercellular adhesiveness of skin fibroblatts from patients and carriers. Hum Genet 63:232–237

    Google Scholar 

  • Jones KW (1980) Muscle cell differentiation and the prospects for the genetic engineering. Br Med Bull 36:173–180

    Google Scholar 

  • Kalofoutis A, Jullien G, Spanos V (1977) Erythrocyte phospholipids in Duchenne muscular dystrophy. Clin Chim Acta 74:85–87

    Google Scholar 

  • Kar NC, Pearson CM (1976) Ca-activated neutral protease in normal and dystrophic human muscle. Clin Chim Acta 73:293–297

    Google Scholar 

  • Kar NC, Pearson CM (1978) Muscular dystrophy and activation of proteinases. Muscle and Nerve 1:308–313

    Google Scholar 

  • Khoklov AP, Malakhovsky VK (1978) Characteristics of cyclic 3′,5′-AMP turnover in patients with progressive muscular atrophy. Vopr Med Khim 27:754–758

    Google Scholar 

  • Kim HD, Luthra MG, Watts RP, Stern LZ (1979) Factors influencing osmotic fragility of Duchenne red blood cells. Ann Neurol 6:153

    Google Scholar 

  • Kingston HM, Thomas NST, Pearson PL, Sarfarazi M, Harper PS (1983) Genetic linkage between Becker muscular dystrophy and a polymorphic DNA sequence on the short arm of the X chromosome. J Med Genet 20:255–258

    Google Scholar 

  • Klassen GA, Blostein R (1969) Adenosine triphosphatase and myopathy. Science 163:492–493

    Google Scholar 

  • Kloepfer HW, Talley C (1958) Autosomal recessive inheritance of Duchenne type muscular dystrophy. Ann Genet 22:138–143

    Google Scholar 

  • Kobayashi T, Mawatari S, Kuroiwa Y (1978) Lipids and proteins of erythrocyte membrane in Duchenne muscular dystrophy. Clin Chim Acta 85:259–266

    Google Scholar 

  • Koehler JP (1974) Blood vessel structure in Duchenne muscular dystrophy. Neurology 24:354

    Google Scholar 

  • Kohlschütter A, Wiesmann UN, Herschkowitz NN, Ferber E (1976) Phospholipid composition of cultivated skin fibroblasts in Duchenne muscular dystrophy. Clin Chim Acta 70:463–465

    Google Scholar 

  • Koski CL, Jungalwala FB, Kolodny EH (1978) Normality of erythrocyte phospholipids in Duchenne muscular dystrophy. Clin Chim Acta 85:295–298

    Google Scholar 

  • Kosower D, Christiansen R, Morton NE (1962) Sporadic cases of hemophilia and the question of a possible sex-difference in mutations. Am J Hum Genet 14:159–169

    Google Scholar 

  • Kuby SA, Keutel HJ, Okabe K, Jacobs HK, Ziter F, Gerber D, Tyler FH (1977) Isolation of human ATP-creatine transphosphorylases (creatine phosphokinases) from tissues of patients with Duchenne muscular dystrophy. J Biol Chem 252:8382–8390

    Google Scholar 

  • Kuby SA, Palmieri RH, Okabe K, Frischat A, Cress MC (1979) Studies on muscular dystrophy: a comparison by physical and chemical means of the normal human ATP-creatine transphosphorylases (creatine kinases) with those from tissues in Duchenne dystrophy. Arch Biochem Biophys 194:236–253

    Google Scholar 

  • Kunze D, Reichmann G, Egger E, Leuschner G, Eckhardt H (1973) Erythrozytenlipide bei progressiver Muskeldystrophie. Clin Chim Acta 43:333–341

    Google Scholar 

  • Kuroiwa Y, Miyazaki T (1967) Epidemiological study of myopathy in Japan. In: Milhorat AT (ed) Exploratory concepts in muscular dystrophy and related disorders. Excerpta Medica, Amsterdam. Int Congr Ser 147, p 98

    Google Scholar 

  • Lane RJM, Maskrey P, Nicholson GA, Siddiqui PQR, Nicholson M, Gascoigne P, Pennington RJT, Gardner-Medwin D, Walton JN (1979) An evaluation of some carrier detection techniques in Duchenne muscular dystrophy. J Neurol Sci 43:377–394

    Google Scholar 

  • Lane RJM, Gardner-Medwin D, Roses AD (1980) Electrocardiographic abnormalities in carriers of Duchenne muscular dystrophy. Neurology 30:497–501

    Google Scholar 

  • Lane RJM, Robinow M, Roses AD (1983) The genetic status of mothers of isolated cases of Duchenne muscular dystrophy. J Med Genet 20:1–11

    Google Scholar 

  • Lange K, Zatz M (1979) A new method for the analysis of age trends in CPK levels with application to Duchenne muscular dystrophy. Hum Hered 29:154–160

    Google Scholar 

  • Leder P (1978) Discontinuous genes. N Engl J Med 298:1079–1081

    Google Scholar 

  • Leibowitz D, Dubowitz V (1981) Intellect and behaviour in Duchenne muscular dystrophy. Dev Med Child Neurol 23:577–590

    Google Scholar 

  • Liechti-Gallati S, Moser H, Siegrist HP, Wiesmann U, Herschkowitz NN (1981) Abnormal growth kinetics and 5′-nucleotidase activities in cultured skin fibroblasts from patients with Duchenne muscular dystrophy. Pediatr Res 15:1411–1414

    Google Scholar 

  • Lindenbaum RH, Clarke G, Patel C, Moncrieff M, Hughes JT (1979) Muscular dystrophy in an X;1 translocation female suggests that Duchenne locus is on X chromosome short arm. J Med Genet 16:389–392

    Google Scholar 

  • Little WJ (1853) On the nature and treatment of the deformities of the human frame: being a course of lectures delivered at the Royal Orthopaedic Hospital in 1843: With numerous notes and additions to the present time. Longman, Brown, Greene & Longmans, pp 14–16

  • Lloyd SJ (1978) Osmotic fragility of erythrocytes in Duchenne muscular dystrophy. Br Med J 2:252

    Google Scholar 

  • Lyon MF (1962) Sex chromatin and gene action in the mammalian X-chromosome. Am J Hum Genet 14:135–148

    Google Scholar 

  • Mahoney MJ, Haseltine FP, Hobbins JC, Banker BQ, Caskey CT, Golbus MS (1977) Prenatal diagnosis of Duchenne's muscular dystrophy. N Engl J Med 297:968–973

    Google Scholar 

  • Marsh GG, Munsat TL (1974) Evidence for early impairment of verbal intelligence in Duchenne muscular dystrophy. Arch Dis Child 49:118–122

    Google Scholar 

  • Matheson DW, Howland JL (1974) Erythrocyte deformation in human muscular dystrophy. Science 184:165–166

    Google Scholar 

  • Matheson DW, Howland JL (1975) Erythrocytes in human muscular dystrophy. Science 187:453–454

    Google Scholar 

  • Maunder-Sewry CA, Dubowitz V (1981) Needle muscle biopsy for carrier detection in Duchenne muscular dystrophy. Part 1. Light microscopy-histology, histochemistry and quantitation. J Neurol Sci 49:305–324

    Google Scholar 

  • Mawatari S, Takagi A, Rowland LP (1974) Adenyl cyclase in normal and pathological human muscle. Arch Neurol 30:96–102

    Google Scholar 

  • Mawatari S, Miranda A, Rowland LP (1976a) Adenyl cyclase abnormality in Duchenne muscular dystrophy: muscle cells in culture. Neurology 26:1021–1026

    Google Scholar 

  • Mawatari S, Schonberg M, Olarte M (1976b) ATPase and adenyl cyclase in erythrocytes of patients with Duchenne muscular dystrophy. Arch Neurol 33:489–493

    Google Scholar 

  • Mawatari S, Igisu H, Kuroiwa Y, Miyoshino S (1981) Na+K+ATPase of erythrocyte membranes in Duchenne muscular dystrophy. Neurology 31:293–297

    Google Scholar 

  • McComas AJ, Sica REP, Currie S (1970) Muscular dystrophy: evidence for a neural factor. Nature 226:1263–1264

    Google Scholar 

  • McComas AJ, Sica REP, Campbell MJ (1971a) An electrophysiological study of Duchenne dystrophy. J Neurol Neurosurg Psychiatry 34:461–468

    Google Scholar 

  • McComas AJ, Sica REP, Campbell MJ (1971b) “Sick” motoneurones: A unifying concept of muscle disease. Lancet i:321–325

    Google Scholar 

  • McComas AJ, Sica REP, Upton ARM (1974) Multiple analysis of motor units in muscular dystrophy. Arch Neurol 30:249–251

    Google Scholar 

  • McLaughlin J, Engel WK (1979) Lipid composition of erythrocytes. Finding in Duchenne's muscular dystrophy and myotonic atrophy. Arch Neurol 36:351–354

    Google Scholar 

  • McMurchie EJ, Williams RE, Sparkes RS, Fox CF (1979) Altered cell surface organization in cultured Duchenne muscular dystrophic fibroblasts. Proc Aust Biochem Soc 12:30

    Google Scholar 

  • Mendell JR, Engel WK, Derrer EC (1971) Duchenne muscular dystrophy: Functional ischemia reproduces its characteristic lesions. Science 172:1143–1145

    Google Scholar 

  • Meryon E (1852) On granular and fatty degeneration of the voluntary muscles. Med Chir Trans 35:73–84

    Google Scholar 

  • Meryon E (1864) Practical and pathological researches on the various forms of paralysis. Churchill, London

    Google Scholar 

  • Miale TP, Frias JL, Lawson DL (1975) Erythrocytes in human muscular dystrophy. Science 187:453–454

    Google Scholar 

  • Milhorat AT, Goldstone L (1965) The carrier state in muscular dystrophy of the Duchenne type. JAMA 194:130–134

    Google Scholar 

  • Miller SE, Roses AD, Appel SH (1975) Erythrocytes in human muscular dystrophy. Science 188:1131

    Google Scholar 

  • Miller SE, Roses AD, Appel SH (1976) Scanning electron microscopy studies in muscular dystrophy. Arch Neurol 33:172–174

    Google Scholar 

  • Miyoshi K, Saito S, Kawai H, Kondo A, Iwasa M, Hayashi T, Yagita M (1978) Radioimmunoassay for human myoglobin: Methods and results in patients with skeletal muscle or myocardial disorders. J Lab Clin Med 92:341–352

    Google Scholar 

  • Mokri B, Engel AG (1975) Duchenne dystrophy: Electronmicroscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber. Neurology 25:1111–1120

    Google Scholar 

  • Monckton G, Marusyk H, Pehowich E (1981) A method for the detection of carriers of Duchenne muscular dystrophy—A preliminary report. Am J Hum Genet 33:978–986

    Google Scholar 

  • Monckton G, Hoskin V, Warren S (1982) Prevalence and incidence of muscular dystrophy in Alberta, Canada. Clin Genet 21:19–24

    Google Scholar 

  • Moosa A, Brown BH, Dubowitz V (1972) Quantitative electromyography: carrier detection in Duchenne type muscular dystrophy using a new automatic technique. J Neurol Neurosurg Psychiatry 35:841–844

    Google Scholar 

  • Morris CJ, Raybould JA (1971) Histochemically demonstrable fibre abnormalities in normal skeletal muscle and in muscle from carriers of Duchenne muscular dystrophy. J Neurol Neurosurg Psychiatry 34:348–352

    Google Scholar 

  • Morris GE, Buzash EA, Bourke AW, Tepperman K, Thompson WC, Heywood SM (1973) Myosin messenger RNA: Studies on its purification, properties and translation during myogenesis in culture. In: The mechanism of muscle contraction. Cold Spring Harbor Symp Quant Biol 37:535–541

  • Morton NE (1958) Segregation analysis in human genetics. Science 127:79–80

    Google Scholar 

  • Morton NE, Chung CS (1959) Formal genetics of muscular dystrophy. Am J Hum Genet 11:360–379

    Google Scholar 

  • Moser H (1976/1977) Bestimmung der Heterozygotenwahrscheinlichkeit bei Angehörigen „sporadischer” Fälle X-chromosomal-rezessiver Erbleiden. Arch Genet 49/50:113–126

    Google Scholar 

  • Moser H (1977) Heterozygotenerfassung und genetische Beratung bei der progressiven Muskeldystrophie Duchenne. Schweiz Rundschau Med (PRAXIS) 66:814–822

    Google Scholar 

  • Moser H (1983) Unpublished data

  • Moser H, Wiesmann U (1971) Serum-Creatin-Kinase und Sulfhydrilarmmuskulatur bei Patienten und Konduktorinnen der progressiven Muskeldystrophie Duchenne. Klin Wschr 49:488–494

    Google Scholar 

  • Moser H, Emery AEH (1974) The manifesting carrier in Duchenne muscular dystrophy. Clin Genet 5:271–284

    Google Scholar 

  • Moser H, Vogt J (1974) Follow-up study of serum-creatine-kinase in carriers of Duchenne muscular dystrophy. Lancet ii:661–662

    Google Scholar 

  • Moser H, Wiesmann U, Richterich R, Rossi E (1964) Progressive Muskeldystrophie. VI. Häufigkeit, Klinik und Genetik der Duchenne-Form. Schweiz Med Wschr 95:1610–1621

    Google Scholar 

  • Moser H, Mumenthaler M, Wiesmann U (1971) Biochemische, histologische und klinische Befunde bei Konduktorinnen der progressiven Muskeldystrophie vom Typ Duchenne. Schweiz Med Wschr 101:537–542; 573–578

    Google Scholar 

  • Munsat TL, Bradley WG (1977) Serum creatine phosphokinase levels and prednisone-treated muscle weakness. Neurology 27:96–97

    Google Scholar 

  • Munsat TL, Baloh R, Pearson CM, Fowler W Jr (1973) Serum enzyme alterations in neuromuscular disorders. JAMA 226:1536–1542

    Google Scholar 

  • Murphy EA, Mutalik GS (1969) The application of Bayesian methods in genetic counselling. Hum Hered 19:126–151

    Google Scholar 

  • Murphy EA, Chase GA (1975) Principles of genetic counseling. Year Book Med Publ, Chicago

    Google Scholar 

  • Murphy EG, Corey PNJ, Conen PE (1964) Varying manifestations of Duchenne muscular dystrophy in a family with affected females. In: Paul WM, Daniel EE, Kay CM, Monckton G (eds) Muscle (Proceedings of Symposium at Faculty of Medicine, University of Alberta). Pergamon, New York, pp 529–546

    Google Scholar 

  • Murray JM, Davies KE, Harper PS, Meredith L, Mueller CR, Williamson R (1982) Linkage relationship of a cloned DNA sequence on the short arm of the X chromosome to Duchenne muscular dystrophy. Nature 300:69–71

    Google Scholar 

  • Nicholson LVB (1981) Serum myoglobin in muscular dystrophy and carrier detection. J Neurol Sci 51:411–426

    Google Scholar 

  • Nicholson GA, Sugars J (1982a) Decreased A 23187-induced chemiluminiscence in Duchenne muscular dystrophy granulocytes. J Neurol Sci 56:11–16

    Google Scholar 

  • Nicholson GA, Sugars J (1982b) An evaluation of lymphocyte capping in Duchenne muscular dystrophy. J Neurol Sci 53:511–518

    Google Scholar 

  • Nicholson GA, Gardner-Medwin G, Pennington RJT, Walton JN (1979) Carrier detection in Duchenne muscular dystrophy: Assessment of the effect of age on detection-rate with serum-creatine-kinase-activity. Lancet i:692–694

    Google Scholar 

  • Nicholson GA, Lane RJM, Gardner-Medwin D, Walton JN (1981) Carrier testing in families of isolated cases of Duchenne muscular dystrophy. Creatine kinase activities in female relatives of mothers with normal CK activity. J Neurol Sci 51:29–42

    Google Scholar 

  • Niebroj-Dobosz I (1976) Erythrocyte ghosts (Na+K+) ATPase activity in Duchenne's dystrophy and myotonia. J Neurol 214:61–69

    Google Scholar 

  • Nomura H, Hizawa K (1982) Histopathological study of the conduction system of the heart in Duchenne progressive muscular dystrophy. Acta Pathol Jpn 32:1027–1033

    Google Scholar 

  • Nordal HJ, Andersson TR, Dietrichson P (1982) Lymphocyte capping: A diagnostic method in progressive muscular dystrophy? Acta Neurol Scand 65:442–447

    Google Scholar 

  • Nørregaard-Hansen K, Sørensen OH (1982) Significance of serum myoglobin in neuromuscular diseases and in carrier-detection of Duchenne muscular dystrophy. Acta Neurol Scand 66:259–266

    Google Scholar 

  • Oberc MA, Engel WK (1977) Ultrastructural localization of calcium in normal and abnormal skeletal muscle. Lab Invest 36:566–577

    Google Scholar 

  • O'Brien T, Harper PS, Davies KE, Murray JM, Sarfarazi M, Williamson R (1983) Absence of genetic heterogeneity in Duchenne muscular dystrophy shown by a linkage study using two cloned DNA sequences. J Med Genet 20:249–251

    Google Scholar 

  • Olson BJ, Fenichel GM (1982) Progressive muscle disease in a young woman with family history of Duchenne's muscular dystrophy. Arch Neurol 39:378–380

    Google Scholar 

  • Osame M, Engel AG, Rebouche CJ, Scott RE (1981) Freeze-fracture electron microscopic analysis of plasma membranes of cultured muscle cells in Duchenne dystrophy. Neurology 31:972–979

    Google Scholar 

  • Panayiotopoulos CP (1974) Electrophysiological estimation of motor units in Duchenne muscular dystrophy. J Neurol Sci 23:89–98

    Google Scholar 

  • Paterson BM, Bishop JO (1977) Changes in the mRNA population of chick myoblasts during myogenesis in vitro. Cell 12:751–765

    Google Scholar 

  • Paulson OB, Engel AG, Gomez MR (1974) Muscle blood flow in Duchenne type muscular dystrophy, limb-girdle dystrophy, polymyositis, and in normal controls. J Neurol Neurosurg Psychiatry 37:685–690

    Google Scholar 

  • Pearce GW, Pearce JMS, Walton JN (1966) The Duchenne type muscular dystrophy: Histopathological studies of the carrier state. Brain 89:109–120

    Google Scholar 

  • Pearce JMS, Pennington RJT, Walton JN (1964) Serum enzyme studies in muscle disease. Part III. Serum creatine kinase activity in relatives of patients with the Duchenne type of muscular dystrophy. J Neurol Neurosurg Psychiatry 27:181–185

    Google Scholar 

  • Pearson CM (1962) Histopathological features of muscle in the preclinical stages of muscular dystrophy. Brain 85:109–120

    Google Scholar 

  • Pearson CM, Fowler WM, Wright SW (1963) X-chromosome mosaicism in females with muscular dystrophy. Proc Natl Acad Sci 50:24–31

    Google Scholar 

  • Pearson TW (1978) (Na++K+)-ATPase of Duchenne muscular dystrophy erythrocyte ghosts. Life Sci 22:127–132

    Google Scholar 

  • Pena DJ (1978) Is Duchenne muscular dystrophy a simple genic disorder? Lancet ii:630

    Google Scholar 

  • Penn AS, Lisak RP, Rowland P (1970) Muscular dystrophy in young girls. Neurology 20:147–159

    Google Scholar 

  • Penn AS, Cloak EA, Rowland LP (1972) Myosin from normal and dystrophic human muscle: immunchemical and electrophoretic studies. Arch Neurol 27:159–173

    Google Scholar 

  • Pennington RJT (1977) Proteinases of muscle. In: Barrett AJ (ed) Proteinases in mammalian cells and tissues. Amsterdam, North Holland Publishing Co, pp 515–543

    Google Scholar 

  • Penrose LS (1955) Parental age and mutation. Lancet ii:312–313

    Google Scholar 

  • Percy ME, Chang LS, Murphy EG, Oss I, Verellen-Dumoulin C, Thompson MW (1979) Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection. Muscle and Nerve 2:329–339

    Google Scholar 

  • Pestronk A, Parhad IM, Drachman DB, Price DL (1982) Membrane myopathy: Morphological similarities to Duchenne muscular dystrophy. Muscle and Nerve 5:209–214

    Google Scholar 

  • Peter JB, Worsfold M (1969) Muscular dystrophy and other myopathies: sarcotubular vesicles in early disease. Biochem Med 2:364–371

    Google Scholar 

  • Peter JB, Worsfold M, Pearson CM (1969) Erythrocyte ghost adenosine triphosphatase in Duchenne dystrophy. J Lab Clin Med 74:103–108

    Google Scholar 

  • Peter JB, Fiehn W, Nagamoto T, Andiman R, Stempel K, Bowman R (1974) Studies of sarcolemma from normal and diseased skeletal muscle. In: Milhorat AT (ed) Exploratory concepts in muscular dystrophy II. Amsterdam, Excerpta Medica, pp 479–490

    Google Scholar 

  • Pfändler U (1950) Eine einfach rezessive Form der Dystrophia musculorum progressiva mit einer Sippenstammtafel aus dem Emmental (Schweiz). Dtsch Med Wschr 75:1221–1225

    Google Scholar 

  • Pickard NA, Gruemer HD, Verrill HL, Isaacs ER, Robinow M, Nance WE, Myers EC, Goldsmith B (1978) Systemic membrane defect in the proximal muscular dystrophies. N Engl J Med 299:841–846

    Google Scholar 

  • Pirro R, Lauro R, Testa I, Ferretti G, De Martinis C, Dellantonio R (1982) Decreased insulin receptors but normal glucose metabolism in Duchenne muscular dystrophy. Science 216:311–313

    Google Scholar 

  • Price R (1763) An essay towards solving a problem in the doctrine of chances. By the late Rev. Mr. Bayes. F.R.S. Philos Trans R Soc Lond 53:370–375

    Google Scholar 

  • Prot J (1971) Genetic-epidemiologic studies in progressive muscular dystrophy. J Med Genet 8:90–96

    Google Scholar 

  • Prosser EJ, Murphy EG, Thompson MW (1969) Intelligence and the gene for Duchenne muscular dystrophy. Arch Dis Child 44:221–230

    Google Scholar 

  • Proudfoot NJ, Maniatis T (1980) The structure of human α-globin pseudogene and its relationship to α-globin gene duplication. Cell 21:537–544

    Google Scholar 

  • Radu H, Stenzel K (1969) Beiträge zum Studium der pseudohypertrophischen Muskeldystrophien. II. Pseudohypertrophische Muskeldystrophie bei Mädchen. Dtsch Z Nervenheilk 196:116–135

    Google Scholar 

  • Radu H, Migea S, Tötök A, Bordeianu L, Radu A (1968) Carrier detection in X-linked Duchenne type muscular dystrophy. Pluridimensional investigation. J Neurol Sci 6:289–300

    Google Scholar 

  • Rao GA, Siler K, Larkin EC (1978) Palmitoleic acid in erythrocytes from carriers of Duchenne muscular dystrophy. Science 200:1416

    Google Scholar 

  • Ratnoff O, Jones PK (1977) The laboratory diagnosis of the carrier state for classic hemophilia. Ann Int Med 86:521–528

    Google Scholar 

  • Ritossa FM, Atwood KC, Spiegleman S (1966) A molecular explanation of the bobbed mutants of Drosophila as partial deficiencies of ribosomal DNA. Genetics 54:819–834

    Google Scholar 

  • Robinson L (1979) Split genes and muscular dystrophy. Muscle and Nerve 2:458–464

    Google Scholar 

  • Rodan GA, Rodan SB, Raible DG, Cutler LS, Wacholtz M, Sha'ari RI (1979) Adenylate cyclase in muscular dystrophy. Ann NY Acad Sci 317:670–691

    Google Scholar 

  • Rodemann HP (1979) Die molekularen Mechanismen des pathophysiologischen Alterns: Untersuchungen an Hautfibroblasten von Patienten mit Duchenne-Muskeldystrophie. Dissertation, Stuttgart-Hohenheim

  • Rosenmann E, Kreis C, Thompson RG, Dobbs M, Hamerton JL, Wrogeman K (1982) Analysis of fibroblast proteins from patients with Duchenne muscular dystrophy by two-dimensional gel electrophoresis. Nature 298:563–565

    Google Scholar 

  • Roses AD (1979) Erythrocyte membranes autophosphorylation in Duchenne muscular dystrophy: effect of two methods of ghost preparation on results. Clin Chim Acta 95:69–74

    Google Scholar 

  • Roses AD, Appel SH (1976) Erythrocyte spectrin peak II phosphorylation in Duchenne muscular dystrophy. J Neurol Sci 29:185–193

    Google Scholar 

  • Roses AD, Herbstreith M, Metcalf B, Appel SH (1976a) Increased phosphorylated components of erythrocyte membrane spectrin band II with reference to Duchenne dystrophy. J Neurol Sci 30:167–178

    Google Scholar 

  • Roses AD, Roses MJ, Miller SE, Hull KL, Appel SH (1976b) Carrier detection in Duchenne muscular dystrophy. N Engl J Med 294:193–198

    Google Scholar 

  • Roses AD, Roses MJ, Metcalf BS, Hull KL, Nicholson GA, Hartwig GB, Roe CR (1977) Pedigree testing in Duchenne muscular dystrophy. Ann Neurol 2:271–278

    Google Scholar 

  • Roses AD, Hartwig GB, Mabry M, Nagano Y, Miller SE (1980) Red blood cell and fibroblast membranes in Duchenne and myotonic muscular dystrophy. Muscle and Nerve 3:36–54

    Google Scholar 

  • Roses AD, Shile PE, Herbstreith MH, Balakrishnan CV (1981) Identification of abnormally (32P)-phosphorylated cyanogen bromide cleavage product of erythrocyte membrane spectrin in Duchenne muscular dystrophy. Neurology 31:1026–1030

    Google Scholar 

  • Roses MS, Nicholson MT, Kircher CS, Roses AD (1977) Evaluation and detection of Duchenne's and Becker's muscular dystrophy carriers by manual muscle testing. Neurology 27:20–25

    Google Scholar 

  • Rott HD, Mulz D (1982) Muskeldystrophie Duchenne: Konduktorinnenerfassung mit Ultraschall. Dtsch med Wschr 107:1678–1681

    Google Scholar 

  • Rott HD, Mulz D (1983) Duchenne's muscular dystrophy: Carrier detection by muscle ultrasound. J Génét Hum 31:63–65

    Google Scholar 

  • Rowland LP (1976) pathogenesis of muscular dystrophies. Arch Neurol 33:315–321

    Google Scholar 

  • Rowland LP (1980) Biochemistry of muscle membranes in Duchenne muscular dystrophy. Muscle and Nerve 3:3–20

    Google Scholar 

  • Rowland LP, Osnos M, Hirschberg E (1960) Serum enzymes in the myopathies. Trans Am Neurol Assoc 85:15–18

    Google Scholar 

  • Roy S, Dubowitz V (1970) Carrier detection in Duchenne muscular dystrophy. A comparative study of electron microscopy, light microscopy and serum enzymes. J Neurol Sci 11:65–79

    Google Scholar 

  • Ruitenbeek W (1978a) The fatty acid composition of various lipid fractions isolated from erythrocytes and blood plasma of patients with Duchenne and congenital myotonic muscular dystrophy.Clin Chim Acta 89:99–110

    Google Scholar 

  • Ruitenbeek W (1979) Membrane-bound enzymes of erythrocytes in human muscular dystrophy: (Na++K+)-ATPase, Ca++-ATPase, K+- and Ca++-p-nitrophenylphosphatase. J Neurol Sci 41:71–80

    Google Scholar 

  • Ruitenbeek W, Edixhoven MJ, Scholte HR (1978b) Osmotic stability of erythrocytes in human muscular dystrophy before and after phospholipase treatment. Clin Chim Acta 94:259–266

    Google Scholar 

  • Sage J, Inati Y, Samaha F (1979) The importance of serum pyruvate kinase in neuromuscular diseases and carrier states. Muscle and Nerve 2:390–393

    Google Scholar 

  • Samaha FJ (1972) Tropomyosin and troponin in normal and dystrophic human muscle. Arch Neurol 26:547–550

    Google Scholar 

  • Samaha FJ, Gergely J (1969) Biochemical abnormalities of the sarcoplasmic reticulum in muscular dystrophy. N Engl J Med 280:184–188

    Google Scholar 

  • Samaha FJ, Congedo CZ (1977) Two biochemical types of Duchenne dystrophy: sarcoplasmic reticulum membrane proteins. Ann Neurol 1:125–130

    Google Scholar 

  • Samaha FJ, Thies WH (1979) Myosin light chains in Duchenne dystrophy and paraplegic muscle. Neurology 29:122–125

    Google Scholar 

  • Sands ME, Harris R (1979) Lymphocyte capping and carrier detection rate in Duchenne muscular dystrophy. Lancet ii:698

    Google Scholar 

  • Sanyl SK, Johnson WW (1982) Cardiac conduction abnormalities in children with Duchenne's progressive muscular dystrophy: Electrocardiographic features and morphologic correlates. Circulation 66:853–863

    Google Scholar 

  • Satapathy RK, Skinner R (1979) Serum creatine kinase levels in normal females. J Med Genet 16:49–51

    Google Scholar 

  • Sato B, Nishikida K, Samuels LT, Tyler FH (1978) Electron spin resonance studies of erythrocytes from patients with Duchenne muscular dystrophy. J Clin Invest 61:251–259

    Google Scholar 

  • Scarlato G, Meola G, Silani V, Manfredi L, Bottiroli G, Zanella A (1979) Erythrocyte spectrofluorometric abnormalities in Duchenne patients and carriers. A new approach to carrier detection. Acta Neurol Scand 59:262–269

    Google Scholar 

  • Scarpalezos S, Panayiotopoulos CP (1973) Duchenne muscular dystrophy: Reservations to the neurogenic hypothesis. Lancet ii:458

    Google Scholar 

  • Shay JW, Cook J, Fuseler JW (1979a) Microtubules and Duchenne muscular dystrophy. Ann Neurol 6:147

    Google Scholar 

  • Shay JW, Fuseler JW (1979b) Diminished microtubules in fibroblast cells derived from inherited dystrophic muscle explants. Nature 278:178–180

    Google Scholar 

  • Shoji S (1981) Calcium flux of erythrocytes in Duchenne muscular dystrophy. J Neurol Sci 51:427–435

    Google Scholar 

  • Sica REP, McComas AJ (1978) The neural hypothesis of muscular dystrophy. A review of recent experimental evidence with particular reference to the Duchenne form. Can J Neurol Sci 5:189–197

    Google Scholar 

  • Siddiqui QR, Pennington RJT (1977) Effect of ouabain upon erythrocyte membrane adenosine triphosphatase in Duchenne muscular dystrophy. J Neurol Sci 34:365–372

    Google Scholar 

  • Silverman LM, Gruemer HD (1976) Sarcolemmal membrane changes related to enzyme release in the imipramine/serotonin experimental animal model. Clin Chem 22:1710–1714

    Google Scholar 

  • Skinner R, Smith C, Emery AEH (1974) Linkage between the loci for benign (Becker-type) X-borne muscular dystrophy and deutan colour blindness. J Med Genet 11:317–320

    Google Scholar 

  • Skinner R, Emery AEH, Scheuerbrandt G, Syme J (1982) Feasibility of neonatal screening for Duchenne muscular dystrophy. J Med Genet 19:1–3

    Google Scholar 

  • Skyring A, McKusick V (1961) Clinical, genetic and electrocardiographic studies in childhood muscular dystrophy. Am J Med Sci 242:534–547

    Google Scholar 

  • Slightom JL, Blechl AE, Smithies O (1980) Human fetal Gγ- and Aγ-globin genes: Complete nucleotide sequences suggest that DNA can be exchanged between these duplicated genes. Cell 21:627–638

    Google Scholar 

  • Smith CAB, Kilpatrick SJ (1958) Estimates of the sex ratio of mutation rates in sex-linked conditions by the method of maximum likelihood. Ann Hum Genet 22:244–249

    Google Scholar 

  • Smith I, Elton RA, Thomson WHS (1979) Carrier detection in X-linked recessive (Duchenne) muscular dystrophy: Serum creatine phosphokinase values in premenarchal menstruating, postmenopausal and pregnant normal women. Clin Chim Acta 98:207–216

    Google Scholar 

  • Soltan HC (1977) Echinocytes in families with Duchenne dystrophy. J Med Genet 14:276–278

    Google Scholar 

  • Somer H, Olarte M (1977) Red blood cells in Duchenne muscular dystrophy: increased osmotic fragility, lack of increased enzyme leakage. Neurology 27:361

    Google Scholar 

  • Somer H, Chien S, Sung LA, Thurn A (1979) Erythrocytes in Duchenne dystrophy: osmotic fragility and membrane deformability. Neurology 29:519–522

    Google Scholar 

  • Souweine G, Bernard JC, Lasne Y, Lachanat J (1978) The sodium pump of erythrocytes from patients with Duchenne muscular dystrophy: effects of ouabain on the active sodium flux and on (Na+, K+)ATPase. J Neurol 217:287–294

    Google Scholar 

  • Spiegler A, Wiedemann G, Herrmann FH, Menzel K, Hoffmann W (1982) Altersabhängigkeit der Creatinkinase-(CK-) Aktivität im Serum: Referenzwerte zur Konduktorinnendiagnostik bei Duchenne-Muskeldystrophie (DMD). Dtsch Gesundheitswesen 37:2009–2013

    Google Scholar 

  • Spowart G, Buckton KE, Skinner R, Emery AEH (1982) X-chromosome in Duchenne muscular dystrophy. Lancet i:1251

    Google Scholar 

  • Sugita H, Tyler FH (1963) Pathogenesis of muscular dystrophy. Trans Assoc Am Physicians 76:231–244

    Google Scholar 

  • Sugita H, Okimoto K, Ebashi S, Okinaka S (1967) Biochemical alterations in progressive muscular dystrophy with special reference to the sarcoplasmic reticulum. In: Milhorat AT (ed) Exploratory concepts in muscular dystrophy and related disorders. Amsterdam, Excerpta Medica Foundation, p 321

    Google Scholar 

  • Susheela AK, Kaul RD, Sachdev K, Singh N (1975) Adenyl cyclase activity in Duchenne dystrophic muscle. J Neurol Sci 24:361–363

    Google Scholar 

  • Sybert VP, Setran KN, Kadin ME (1979) Lymphocyte capping in carriers of Duchenne muscular dystrophy. N Engl J Med 301:724–725

    Google Scholar 

  • Schapira G, Dreyfus JC, Schapira F (1953) L'élévation du taux de l'aldolase sérique: test biochimique de myopathies. Sem Hôp Paris 29:1917–1921

    Google Scholar 

  • Schmalbruch H (1975) Segmental fibre breakdown and defects of the plasmalemma in diseased human muscles. Acta Neuropathol 33:129–141

    Google Scholar 

  • Schmalbruch H (1979) A freeze-fracture study of the plasma membrane of muscle fibers of a patient with chronic creatine kinase elevation suspected for malignant hyperthermia. J Neuropathol Exp Neurol 38:407–418

    Google Scholar 

  • Scholte HR, Busch HMF (1979) 5′-nucleotidase activity in Duchenne muscular dystrophy. N Engl J Med 301:726

    Google Scholar 

  • Scholte HR, Busch HFM (1980) Decreased phosphorylase activity in leucocytes of Duchenne carriers. Clin Chim Acta 105:137–139

    Google Scholar 

  • Schotland DL, Bonilla E, Wakayama Y (1981) Freeze-fracture studies of muscle plasma membrane in human muscular dystrophy. Acta Neuropathol 54:189–197

    Google Scholar 

  • Statham HE, Witkowsky JA, Dubowitz V (1979) Protein degradation in skin fibroblasts from patients with Duchenne muscular dystrophy. Biochem J 192:257–262

    Google Scholar 

  • Statham HE, Dubowitz V (1979) Duchenne muscular dystrophy: 45Ca exchange in cultured skin fibroblasts and the effect of calcium ionophore A 23187. Clin Chim Acta 96:225–231

    Google Scholar 

  • Stengel-Rutkowski L, Scheuerbrandt G, Beckmann R, Pongratz D (1977) Prenatal diagnosis of Duchenne's muscular dystrophy. Lancet i:1359–1360

    Google Scholar 

  • Stephens FE, Tyler FH (1951) Studies in disorders of muscle. V. The inheritance of childhood progressive muscular dystrophy in 33 kindreds Am J Hum Genet 3:111–125

    Google Scholar 

  • Stephens J, Lewin E (1965) Serum enzyme variations and histological abnormalities in the carrier state in Duchenne dystrophy. J Neurol Neurosurg Psychiatry 28:104–108

    Google Scholar 

  • Stern LM (1972) Four cases of Duchenne-type muscular dystrophy in girls. Med J Aust 2:1066–1069

    Google Scholar 

  • Stern CMM, Kahan MC, Dubowitz V (1979) Lymphocyte capping in Duchenne muscular dystrophy. Lancet i:1300

    Google Scholar 

  • Stevenson AC (1958) Muscular dystrophy in Northern Ireland. IV. Some additional data. Ann Hum Genet 22:231–234

    Google Scholar 

  • Takagi A, Schotland DL, Rowland LP (1973) Sarcoplasmic reticulum in Duchenne dystrophy. Arch Neurol 28:380–384

    Google Scholar 

  • Takahashi K, Takao H, Takai T (1978) Adenylate cyclase in Duchenne and Fukuyama type muscular dystrophy. Kobe J Med Sci 24:193–198

    Google Scholar 

  • Tartof KD (1975) Redundant genes. Ann Rev Genet 9:355–385

    Google Scholar 

  • Ten Kate LP, Offringa PJ (1981) The significance of different types of information in calculating the probability that a female relative of a Duchenne muscular dystrophy patient is a carrier. Clin Genet 20:281–288

    Google Scholar 

  • Testard R, Mendolia M, Larget-Piet L, Williamson C, Delaitre R (1973) A propos d'une myopathie de Duchenne de Boulogne chez une fille. Ouest Méd Paris 26:1175–1178

    Google Scholar 

  • Thompson CE (1978) Reproduction in Duchenne dystrophy. Neurology 28:1045–1047

    Google Scholar 

  • Thompson RG, Sponder ES, Rosenmann E, Hamerton JL, Wrogeman K (1982) Proline incorporation by cultured skin fibroblasts from patients with Duchenne muscular dystrophy. J Neurol Sci 57:41–54

    Google Scholar 

  • Thomson WHS (1969) The biochemical identification of the carrier state in X-linked recessive (Duchenne) muscular dystrophy. Clin Chim Acta 26:207–221

    Google Scholar 

  • Thomson WHS (1979) Carrier-detection rate and age in Duchenne muscular dystrophy. Lancet i:829

    Google Scholar 

  • Thomson WHS, Sweeting JC, Hamilton IJD (1975) ATP and muscle enzyme efflux after physical exertion. Clin Chim Acta 59:241–245

    Google Scholar 

  • Tomkins JK (1980) The molecular defect in Duchenne muscular dystrophy. Muscle and Nerve 3:529–530

    Google Scholar 

  • Tomlinson BE, Walton JN, Irving D (1974) Spinal cord limb motor neurones in muscular dystrophy. J Neurol Sci 22:305–327

    Google Scholar 

  • Tzvetanova E (1971) Aldolase isoenzymes in serum and muscle from patients with progressive muscular dystrophy and from human foetus. J Neurol Sci 14:483–489

    Google Scholar 

  • Valli G, Scarlato G, Contartese M (1976) Quantitative electromyography in the detection of the carriers in Duchenne type muscular dystrophy. J Neurol 212:139–149

    Google Scholar 

  • Vasiljevic ZM, Polic DD (1983) Morphological changes of erythrocytes in patients and carriers of Duchenne disease. Acta Neurol Scand 67:242–244

    Google Scholar 

  • Vassella F, Richterich R, Rossi E (1965) The diagnostic value of serum creatine kinase in neuromuscular and muscular disease. Pediatrics 35:322–330

    Google Scholar 

  • Verellen C, Freund M, DeMeyer R, Laterre C, Scholberg B, Frédéric J (1977) Progressive muscular dystrophy of the Duchenne type in a young girl associated with an aberration of chromosome X. Excerpta Medica Int Congr Ser 426, p 42

    Google Scholar 

  • Verril HL, Pickard NA, Gruemer HD (1977) Diminished cap formation in lymphocytes from patients and carriers of Duchenne muscular dystrophy. Clin Chem 23:2341–2343

    Google Scholar 

  • Vickers JD, McComas AJ, Rathbone MP (1978) Alterations of membrane phosphorylation in erythrocyte membranes from patients with Duchenne muscular dystrophy. Can J Neurol Sci 5:437–442

    Google Scholar 

  • Vignos PJ, Farah M, Evans E (1978) Affection cardiaque dans la dystrophie musculaire de Duchenne. Une étude échocardiographique préliminaire et clinique. Cahiers Rééd Réadapt 13:277–283

    Google Scholar 

  • Vogel F (1955) Vergleichende Betrachtungen über die Mutationsrate der geschlechtsgebunden-rezessiven Hämophilieformen in der Schweiz und Dänemark. Blut 1:91–109

    Google Scholar 

  • Vogel F (1956) Über die Prüfung von Modellvorstellungen zur spontanen Mutabilität an menschlichem Material. Z Menschl Vererb Konstitutionsl 33:470–491

    Google Scholar 

  • Vogel F (1958) Gedanken über den Mechanismus einiger spontanen Mutationen beim Menschen. Z Menschl Vererb Konstitutionsl 34:389–399

    Google Scholar 

  • Vogel F (1965) Sind die Mutationsraten für die X-chromosomal recessiven Haemophilieformen in Keimzellen von Frauen niedriger als in Keimzellen von Männern? Humangenetik 1:253–263

    Google Scholar 

  • Vogel F (1977) A probable sex difference in some mutation rates. Am J Hum Genet 29:312–319

    Google Scholar 

  • Vogel F, Rathenberg R (1975) Spontaneous mutations in man. In: Harris H, Hirschhorn K (eds) Advances in human genetics, vol 5. Plenum Press, New York London

    Google Scholar 

  • Vogel F, Motulsky AG (1979) Human genetics. Problems and approaches. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Wacholtz MC, Raible DG, Jackowski S, Rodan SB, Rodan GA, Sha'afi RI (1979) Adenylate cyclase and ATPase activities in red cell membranes of patients and genetic carriers of Duchenne muscular dystrophy. Clin Chim Acta 96:255–259

    Google Scholar 

  • Walton JN (1955) On the inheritance of muscular dystrophy. Ann Hum Genet 20:1–38

    Google Scholar 

  • Walton JN (1957) The inheritance of muscular dystrophy. Acta Genet Stat Med 7:318–320

    Google Scholar 

  • Walton JN, Gardner-Medwin D (1981) Progressive muscular dystrophy and the myotonic disorders. In: Walton JN (ed) Disorders of voluntary muscle, 4th ed. Churchill Livingstone, Edinburgh London Melbourne New York, pp 481–524

    Google Scholar 

  • Wassner SJ, Li JB, Ladda RL, Lorenz RP, Emery AEH (1982) Prenatal diagnosis of Duchenne muscular dystrophy: Failure of amniotic fluid and maternal serum NT-methylhistidine analyses to detect affected fetuses. Am J Obstet Gynecol 143:216–219

    Google Scholar 

  • Wertz RL, Roses AD (1982) Letter to the editor: premature aging of fibroblasts from patients with Duchenne muscular dystrophy. Pediatr Res 16:589–590

    Google Scholar 

  • Wieacker P, Davies K, Pearson P, Ropers HH (1983) Carrier detection in Duchenne muscular dystrophy by use of cloned DNA sequences. Lancet i:1325–1326

    Google Scholar 

  • Wilkerson LS, Perkins RC, Roelofs R, Swift L, Dalton LR, Park JH (1978) Erythrocyte membrane abnormalities in Duchenne muscular dystrophy monitored by saturation transfer electron paramagetic resonance spectroscopy. Proc Natl Acad Sci USA 75:838–841

    Google Scholar 

  • Wilson KM, Evans KA, Carter CO (1965) Creatine kinase levels in women who carry genes for three types of muscular dystrophy. Br Med J 1:750–753

    Google Scholar 

  • Williams WR, Thompson MW, Morton NE (1983) Complex segregation analysis and computer-assisted genetic risk assessment for Duchenne muscular dystrophy. Am J Med Genet 14:315–333

    Google Scholar 

  • Winter RM (1980) Estimation of male to female ratio of mutation rates from carrier-detection tests in X-linked disorders. Am J Hum Genet 32:582–588

    Google Scholar 

  • Winter RM, Pembrey ME (1982) Does unequal crossing over contribute to the mutation rate in Duchenne muscular dystrophy? Am J Med Genet 12:437–441

    Google Scholar 

  • Wood DS, Sorenson M, Eastwood AB, Charash WE, Reuben JP (1978) Duchenne dystrophy: abnormal generation of tension and Ca++ regulation in single skinned fibers. Neurology 28:447–457

    Google Scholar 

  • Worden DK, Vignos PJ Jr (1962) Intllectual function in childhood progressive muscular dystrophy. Pediatrics 29:968–977

    Google Scholar 

  • Wrogeman K, Pena SDJ (1976) Mitochondrial calcium overload: a general mechanism for cell-necrosis in muscle diseases. Lancet i:672–673

    Google Scholar 

  • Wyatt PR, Cox DM (1977) Duchenne's muscular dystrophy: Studies in cultured fibroblasts. Lancet i:172–174

    Google Scholar 

  • Yasmineh WG, Ibrahim GA, Abbasnezhad M, Awad EA (1978) Isoenzyme distribution of creatine kinase and lactate dehydrogenase in serum and skeletal muscle in Duchenne muscular dystrophy, collagen disease, and other muscular disorders. Clin Chem 24:1985–1988

    Google Scholar 

  • Yasuda N, Kondo K (1980) No sex difference in mutation rates of Duchenne muscular dystrophy. J Med Genet 17:106–111

    Google Scholar 

  • Yasuda N, Kondo K (1982) The effect of parental age on rate of mutation for Duchenne muscular dystrophy. Am J Med Genet 13:91–99

    Google Scholar 

  • Yoshioka M, Okuda R (1977) Human skeletal muscle fibers in normal and pathological states. Freeze-etch replica observations. J Electron Microsc 26:103–110

    Google Scholar 

  • Yoshioka M (1981) Clinically manifesting carriers in Duchenne muscular dystrophy. Clin Genet 20:6–12

    Google Scholar 

  • Zatz M, Otto PA (1980) Effect of age on the detection rate in Duchenne muscular dystrophy. J Neurol Sci 47:407–410

    Google Scholar 

  • Zatz M (1983) Effect of genetic counseling on Duchenne muscular dystrophy families in Brazil. Am J Med Genet 15:483–490

    Google Scholar 

  • Zatz M, Frota-Pessoa O, Peres CA (1975) Use of normal daughters' CPK levels in the estimation of heterozygosity risks in X-linked muscular dystrophies. Hum Hered 25:354–359

    Google Scholar 

  • Zatz M, Frota-Pessoa A, Levy JA, Peres CA (1976) Creatine phosphokinase (CPK) activity in relatives of patients with X-linked muscular dystrophies: A Brazilian study. J Génét Hum 24:153–168

    Google Scholar 

  • Zatz M, Shapiro LJ, Campion DS, Kaback MM, Otto PA (1980) Serum pyruvatekinase (PK) and creatine-phosphokinase (CPK) in female relatives and patients with X-linked muscular dystrophies (Duchenne and Becker). J Neurol Sci 46:267–279

    Google Scholar 

  • Zatz M, Vianna-Morgante AM, Campos P, Diament AJ (1981) Translocation (X;6) in a female with Duchenne muscular dystrophy: implications for the localization of the DMD locus. J Med Genet 18:442–447

    Google Scholar 

  • Zatz M, Karp LE, Rogatka A (1982) Pyruvate-kinase (PK) and creatine-kinase (CK) in normal pregnancy and its implication in genetic counseling of Duchenne muscular dystrophy (DMD). Am J Med Genet 13:257–262

    Google Scholar 

  • Zatz M, Passos MR, Bortolini ER (1983) Letter to the editor: Serum pyruvate-kinase (PK) activity during pregnancy in potential carriers for Duchenne muscular dystrophy. Am J Med Genet 15:149–151

    Google Scholar 

  • Zellweger H, Niedermeyer E (1965) Central nervous system manifestations in childhood muscular dystrophy. I. Psychometric and electroencephalographic findings. Ann Paediatr 205:25–42

    Google Scholar 

  • Zellweger H, Hanson JW (1968) Psychometric studies in muscular dystrophy type IIIa (Duchenne). Dev Med Child Neurol 9:576–581

    Google Scholar 

  • Zellweger H, Antonik A (1975) Newborn screening for Duchenne muscular dystrophys. Pediatrics 55:30–34

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was dedicated to Professor P.E. Becker in honour of his 75th birthday

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moser, H. Duchenne muscular dystrophy: Pathogenetic aspects and genetic prevention. Hum Genet 66, 17–40 (1984). https://doi.org/10.1007/BF00275183

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00275183

Keywords

Navigation